Logo

Bruker Shares Up 6.7 Percent After CEO Laukien Buys $666K Worth of Stock

May 12, 2005

NEW YORK, May 12 (GenomeWeb News) - Bruker Biosciences CEO Frank Laukien bought more than $666,000 worth of his company's stock since Tuesday, sending the shares up 6.7 percent to $3.83 in mid-afternoon trading today.

 

According to Insidercow.com, which tracks insider trading at public companies, Laukien bought 176,365 shares at prices between $3.60 and $3.80 per share for a total cost of $666,105.30.

Breaking News
The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.